Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Oct 19, 2016 $8.70 $8.70 $8.70 $8.70 164 300
Oct 18, 2016 $8.70 $8.70 $8.70 $8.70 153 900
Oct 17, 2016 $8.30 $8.30 $8.30 $8.30 221 800
Oct 14, 2016 $8.33 $8.33 $8.33 $8.33 171 400
Oct 13, 2016 $8.55 $8.55 $8.55 $8.55 219 000
Oct 12, 2016 $8.68 $8.68 $8.68 $8.68 194 300
Oct 11, 2016 $9.35 $9.35 $9.35 $9.35 102 700
Oct 10, 2016 $9.60 $9.60 $9.60 $9.60 237 500
Oct 07, 2016 $9.45 $9.45 $9.45 $9.45 203 000
Oct 06, 2016 $10.07 $10.07 $10.07 $10.07 268 400
Oct 05, 2016 $10.18 $10.18 $10.18 $10.18 245 200
Oct 04, 2016 $9.98 $9.98 $9.98 $9.98 273 600
Oct 03, 2016 $10.04 $10.04 $10.04 $10.04 320 000
Sep 30, 2016 $9.78 $9.78 $9.78 $9.78 171 100
Sep 29, 2016 $9.88 $9.88 $9.88 $9.88 411 600
Sep 28, 2016 $9.61 $9.61 $9.61 $9.61 533 100
Sep 27, 2016 $9.21 $9.21 $9.21 $9.21 333 500
Sep 26, 2016 $8.91 $8.91 $8.91 $8.91 397 900
Sep 23, 2016 $8.96 $8.96 $8.96 $8.96 384 400
Sep 22, 2016 $8.89 $8.89 $8.89 $8.89 149 000
Sep 21, 2016 $8.89 $8.89 $8.89 $8.89 320 800
Sep 20, 2016 $8.82 $8.82 $8.82 $8.82 348 900
Sep 19, 2016 $8.58 $8.58 $8.58 $8.58 318 700
Sep 16, 2016 $8.92 $8.92 $8.92 $8.92 503 300
Sep 15, 2016 $8.62 $8.62 $8.62 $8.62 556 500
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT